Pentasa®

INN: mesalamine

Approved for use in:

Crohn’s Disease (mild-moderate)
Ulcerative Colitis (mild-moderate)

Type/Class

5-aminosalicylic acid (5-ASA)

Delivery Route

Oral (tablet)
Rectal (enema, suppository)

Health Canada Approval

1994

Storage

Store below 25°C, keep in original package.

Use in Older Adults (65+)

Individuals with impaired renal function may be at greater risk of toxic reactions.

Pregnancy Indication

May cause adverse pregnancy outcomes; only use if benefits outweigh risks.

Breastfeeding Indication

Has been detected in breast milk; may cause diarrhea in breastfed infants.

Pediatric Indication

Not authorized.

Learn More

View the Pentasa® product monograph.